193153-60-5 Usage
Uses
Used in Pharmaceutical Research:
4-Pyridinemethanamine,N-cyclopropyl-(9CI) is used as a building block in pharmaceutical research for the preparation of biologically active molecules. Its cyclopropyl group makes it a valuable intermediate for the synthesis of compounds with potential therapeutic applications.
Used in Medicinal Chemistry:
In medicinal chemistry, 4-Pyridinemethanamine,N-cyclopropyl-(9CI) is used as a key intermediate for the development of new drugs. Its unique structural properties allow for the creation of molecules with specific biological activities, making it a valuable asset in drug discovery and development.
Used in Agrochemical Development:
4-Pyridinemethanamine,N-cyclopropyl-(9CI) also has potential applications in the development of agrochemicals. Its unique chemical properties can be utilized to create compounds with pesticidal or herbicidal activities, contributing to the advancement of agricultural chemicals.
Used in Specialty Chemicals:
In the specialty chemicals industry, 4-Pyridinemethanamine,N-cyclopropyl-(9CI) can be used to develop compounds with specific applications, such as in materials science, coatings, or other industrial processes. Its unique structure and properties make it a versatile building block for creating tailored chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 193153-60-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,3,1,5 and 3 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 193153-60:
(8*1)+(7*9)+(6*3)+(5*1)+(4*5)+(3*3)+(2*6)+(1*0)=135
135 % 10 = 5
So 193153-60-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2/c1-2-9(1)11-7-8-3-5-10-6-4-8/h3-6,9,11H,1-2,7H2
193153-60-5Relevant academic research and scientific papers
PYRIDAZINONE DERIVATIVES AND USE THEREOF AS P2X7 RECEPTOR INHIBITORS
-
Page/Page column 120, (2009/06/27)
Novel pyridazinone compounds of formula (I), which inhibit the purinergic P2X7 receptor and are useful for prevention, therapy and improvement of inflammatory and immunological diseases.
RENIN INHIBITORS
-
Page/Page column 55, (2008/06/13)
The present invention relates to novel renin inhibitors of the general Formula (I), and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds. These novel renin inhibitors are used in treating cardiovascular events and renal insufficiency.
